Degenerative Neurological and Neuromuscular Disease
Scope & Guideline
Exploring breakthroughs in neurological health.
Introduction
Aims and Scopes
- Neurodegenerative Diseases:
The journal extensively covers research on neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease, exploring their pathophysiology, biomarkers, and therapeutic interventions. - Neuromuscular Disorders:
Research on neuromuscular diseases, including but not limited to Duchenne muscular dystrophy and myasthenia gravis, is a core focus, addressing both clinical manifestations and potential treatment strategies. - Innovative Therapies and Interventions:
The publication emphasizes novel therapeutic approaches, including pharmacological treatments, lifestyle interventions, and complementary therapies like acupuncture, highlighting their efficacy and mechanisms. - Biomarkers and Diagnostic Tools:
There is a strong emphasis on identifying and validating biomarkers for early diagnosis and monitoring disease progression, with particular attention to blood and serum-based biomarkers. - Quality of Life and Patient-Centered Research:
The journal also prioritizes studies that assess the impact of various diseases and treatments on patients' quality of life, advocating for holistic and patient-centered care.
Trending and Emerging
- Blood Biomarkers for Alzheimer’s Disease:
There is a notable increase in studies exploring blood biomarkers, which are crucial for early diagnosis and monitoring of Alzheimer's disease, reflecting advancements in detection technologies. - Multimodal Interventions for Quality of Life:
Research focusing on comprehensive lifestyle interventions, such as diet and exercise programs, designed to improve the quality of life for patients with multiple sclerosis and other neurodegenerative conditions is on the rise. - Neuroinflammation and Neuroprotective Strategies:
Emerging studies are increasingly investigating the role of neuroinflammation in neurodegenerative diseases, with a focus on neuroprotective strategies that target inflammatory pathways. - Case Reports and Newborn Screening:
There is a growing trend towards detailed case reports and advocacy for newborn screening in conditions like cerebral adrenoleukodystrophy, highlighting a shift towards early detection and intervention. - Sexual Health in Neurological Disorders:
Research addressing sexual health and motivation in individuals with neurological disorders is gaining attention, emphasizing the importance of holistic care that includes sexual well-being.
Declining or Waning
- Traditional Herbal Medicine:
The interest in traditional herbal remedies for treating neurodegenerative diseases, while still present, has been overshadowed by more contemporary pharmacological approaches and clinical trials. - Vitamin D and Neurological Health:
Research specifically linking vitamin D deficiency to neurological conditions, such as Parkinson's disease, has seen a decrease, possibly due to inconclusive results and a shift towards more complex biochemical interactions. - Sex Differences in Neurological Outcomes:
While sex differences were previously a significant focus, recent publications indicate a waning interest in this area, as research moves towards more integrated approaches that do not segregate findings by sex.
Similar Journals
Nature Reviews Neurology
Transforming Insights into Innovations in Neurological Care.Nature Reviews Neurology, published by NATURE PORTFOLIO, stands as a leading scholarly journal dedicated to the field of neurology and neuroscience. With an impressive impact factor and a prestigious Q1 categorization in both Cellular and Molecular Neuroscience and Clinical Neurology, this journal provides cutting-edge reviews and insights into the latest research developments, trends, and clinical practices. Based in the United Kingdom and accessible to a global audience, Nature Reviews Neurology aims to foster knowledge dissemination and interdisciplinary collaboration among researchers, healthcare professionals, and educators. With an influential Scopus ranking, it remains a pivotal resource for those seeking to deepen their understanding of neurological disorders and therapies while remaining at the forefront of academic discourse and innovation in the field.
Neurodegenerative Diseases
Innovating therapeutic interventions for neurological health.Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Elevating clinical practice through cutting-edge research.JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.
NEUROMUSCULAR DISORDERS
Pioneering research for better patient outcomes.NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.
Annals of Indian Academy of Neurology
Advancing Neurological Insights for a Healthier TomorrowAnnals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.
Journal of Movement Disorders
Fostering collaboration in movement disorder research.The Journal of Movement Disorders, published by the Korean Movement Disorders Society, is a premier open access journal dedicated to advancing the field of neurology with a specific focus on movement disorders. Established in 2008 and indexed with ISSN 2005-940X and E-ISSN 2093-4939, this journal plays a vital role in disseminating high-quality research and clinical insights to a global audience. With an impressive Q2 ranking in both Neurology and Clinical Neurology categories for 2023, the journal continues to feature innovative research articles that contribute to better understanding and management of various movement disorders. Ranked 104th out of 400 in Clinical Neurology and 54th out of 192 in Neuroscience, the Journal of Movement Disorders offers an essential platform for researchers, healthcare professionals, and students alike, fostering collaboration and knowledge exchange in a rapidly evolving field.
KLINISCHE NEUROPHYSIOLOGIE
Exploring the intersection of physiology and neurology.KLINISCHE NEUROPHYSIOLOGIE is a pivotal journal dedicated to advancing the field of clinical neurophysiology, published by GEORG THIEME VERLAG KG in Germany. With an ISSN of 1434-0275 and an E-ISSN of 1439-4081, this journal aims to disseminate high-quality research findings that enhance our understanding of neurological disorders and their physiological underpinnings. Although currently positioned in the fourth quartile in both Neurology (clinical) and Physiology (medical) categories, the journal offers a unique platform for novel insights and empirical studies, filling a crucial niche within the medical community. Researchers, healthcare professionals, and students can benefit from its Open Access option, which promotes wider accessibility and engagement with cutting-edge scientific discourse. As the journal converges through the years from 1998 to 2024, it remains committed to fostering scholarly collaboration and innovation in neurophysiological research, crucial for improving clinical outcomes.
JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS
Bridging the Gap Between Musculoskeletal and Neuronal HealthJOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, published by JMNI in Greece, serves as a vital platform for disseminating cutting-edge research in the fields of musculoskeletal and neuronal sciences. Established in 2002, this journal has continued to evolve, presenting studies that bridge the critical interactions between musculoskeletal health and neuronal function. With a current impact factor reflected in its rankings, it holds a Q3 classification in Endocrinology, Diabetes and Metabolism, and a Q2 classification in Orthopedics and Sports Medicine, alongside Q3 in Physiology, placing it prominently within the academic landscape. The journal's accessibility, while not officially labeled as Open Access, ensures that valuable research findings are available to an international audience of researchers, professionals, and students committed to advancing the understanding of human health. The depth and breadth of content in the JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS underscore its importance in fostering innovation and collaboration across related disciplines, making it a must-read for those invested in the future of musculoskeletal and neuronal research.
Turkish Journal of Neurology
Exploring the frontiers of neurology in Turkey and beyond.Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.
EUROPEAN JOURNAL OF NEUROLOGY
Pioneering Research at the Forefront of Neurology.EUROPEAN JOURNAL OF NEUROLOGY, published by WILEY, stands as a leading platform for the dissemination of innovative research and clinical developments in the field of neurology. With a robust impact factor and prestigious rankings, including being positioned as Q1 in both Neurology and Clinical Neurology categories, the journal plays a pivotal role in shaping neurological sciences from 1994 to 2024. Its Scopus rank highlights its importance, being in the 88th percentile for clinical neurology and 87th percentile for neuroscience. Located in the United Kingdom, the journal thrives as a vital resource for researchers, clinicians, and students dedicated to improving neurological health outcomes. Although it does not offer Open Access, its subscription-based model ensures high-quality peer-reviewed articles are accessible to a global audience, reflecting the continuous pursuit of excellence in neurological research and patient care.